US court overturns Ranbaxy bid to block launch of rival generic drugs – The Economic Times

A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc’s heartburn pill Nexium and Roche’s antiviral Valcyte, a court filing showed.

Read more – The Economic Times